Cancer cells can evade the immune system by altering the expression of molecules involved in immune recognition. For instance, they may downregulate MHC class I molecules, which are necessary for presenting tumor antigens to cytotoxic T cells. Additionally, cancer cells can express immune checkpoint molecules like PD-L1, which interact with PD-1 receptors on T cells to inhibit their activity, thereby avoiding immune-mediated cell death.
